Literature DB >> 20559914

Stem cell therapy trials: a call for standardization.

Leslie W Miller1.   

Abstract

There are currently 25 new clinical cellular therapy trials in progress for cardiovascular disease in the US, and a similar number ongoing in Europe. The lack of standardization in cell isolation, preparation, storage, and time and localization of delivery, present clear hurdles to this growing field. This emphasizes the need for an organized task force to work closely with the FDA to agree upon standardized methods with the end result being improvements in patient care and enhanced knowledge in the field.

Entities:  

Mesh:

Year:  2008        PMID: 20559914     DOI: 10.1007/s12265-008-9042-0

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  19 in total

Review 1.  Unchain my heart: the scientific foundations of cardiac repair.

Authors:  Stefanie Dimmeler; Andreas M Zeiher; Michael D Schneider
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings.

Authors:  Hans F R Dohmann; Emerson C Perin; Christina M Takiya; Guilherme V Silva; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria-Isabel D Rossi; Bernardo M O Pascarelli; Isabella M Assis; Helio S Dutra; João A R Assad; Rodrigo V Castello-Branco; Cantidio Drummond; Hans J F Dohmann; James T Willerson; Radovan Borojevic
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

Review 3.  Methods of stem cell delivery in cardiac diseases.

Authors:  Emerson C Perin; Javier López
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2006-03

Review 4.  Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring.

Authors:  Peter Oettgen; Andrew J Boyle; Steven P Schulman; Joshua M Hare
Journal:  Circulation       Date:  2006-07-25       Impact factor: 29.690

5.  Cardiac cell therapy--mixed results from mixed cells.

Authors:  Anthony Rosenzweig
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

6.  The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart.

Authors:  Jozef Bartunek; Stephanie Dimmeler; Helmut Drexler; Francisco Fernández-Avilés; Manuel Galinanes; Stefan Janssens; John Martin; Anthony Mathur; Phillipe Menasche; Sylvia Priori; Bodo Strauer; Michal Tendera; William Wijns; Andreas Zeiher
Journal:  Eur Heart J       Date:  2006-03-16       Impact factor: 29.983

7.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

8.  Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction.

Authors:  C Griesel; H-G Heuft; D Herrmann; A Franke; D Ladas; N Stiehler; A Stucki; M Braun; K C Wollert; G P Meyer; H Drexler; B Hertenstein; A Ganser; W Rüdinger; L Arseniev
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

9.  Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.

Authors:  Florian H Seeger; Torsten Tonn; Nicola Krzossok; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Eur Heart J       Date:  2007-02-13       Impact factor: 29.983

10.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

View more
  4 in total

1.  Oversight and management of a cell therapy clinical trial network: experience and lessons learned.

Authors:  Lemuel A Moyé; Shelly L Sayre; Lynette Westbrook; Beth C Jorgenson; Eileen Handberg; Saif Anwaruddin; Kristi A Wagner; Sonia I Skarlatos
Journal:  Contemp Clin Trials       Date:  2011-05-17       Impact factor: 2.226

2.  Translating research into clinical scale manufacturing of mesenchymal stromal cells.

Authors:  Karen Bieback; Sven Kinzebach; Marianna Karagianni
Journal:  Stem Cells Int       Date:  2011-01-20       Impact factor: 5.443

Review 3.  Cardiac cell repair therapy: a clinical perspective.

Authors:  Bernard J Gersh; Robert D Simari; Atta Behfar; Carmen M Terzic; Andre Terzic
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616

4.  Mesenchymal stem cells for cardiac regeneration: translation to bedside reality.

Authors:  Mohammad T Elnakish; Fatemat Hassan; Duaa Dakhlallah; Clay B Marsh; Ibrahim A Alhaider; Mahmood Khan
Journal:  Stem Cells Int       Date:  2012-06-07       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.